606 related articles for article (PubMed ID: 28264726)
1. Evaluation of metabolic response with
Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G
Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114
[TBL] [Abstract][Full Text] [Related]
3. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
[TBL] [Abstract][Full Text] [Related]
4. Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor.
Moon SH; Kim HS; Cho YS; Sun JM; Ahn JS; Park K; Kim BT; Ahn MJ; Lee KH
Lung Cancer; 2016 Oct; 100():24-29. PubMed ID: 27597277
[TBL] [Abstract][Full Text] [Related]
5. Texture analysis of
Nakajo M; Jinguji M; Shinaji T; Nakajo M; Aoki M; Tani A; Sato M; Yoshiura T
Br J Radiol; 2018 Feb; 91(1083):20170546. PubMed ID: 29182373
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms.
Shinya T; Tanaka T; Soh J; Matsushita T; Sato S; Toyooka S; Yoshino T; Miyoshi S; Kanazawa S
Acta Med Okayama; 2017 Apr; 71(2):105-112. PubMed ID: 28420891
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
8. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
Zhao J; Wang H; Li Q
Nucl Med Commun; 2020 Apr; 41(4):405-410. PubMed ID: 32032191
[TBL] [Abstract][Full Text] [Related]
9. Multiparameter diagnostic model based on
Wang G; Du L; Lu X; Liu J; Zhang M; Pan Y; Meng X; Xu X; Guan Z; Yang J
BMC Cancer; 2022 Aug; 22(1):895. PubMed ID: 35974323
[TBL] [Abstract][Full Text] [Related]
10. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
[TBL] [Abstract][Full Text] [Related]
11. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.
Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W
Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782
[No Abstract] [Full Text] [Related]
12. Diagnostic and prognostic values of 2-[
Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Vallius T; Peter A; Auranen A; Carpén O; Kemppainen J; Matomäki J; Oksa S; Roering P; Seppänen M; Grénman S; Hynninen J
Gynecol Oncol; 2016 Jan; 140(1):29-35. PubMed ID: 26515076
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results.
Buchbender C; Kuemmel S; Hoffmann O; Stahl AR; Kimmig R; Otterbach F; Ladd S; Koeninger A; Forsting M; Bockisch A; Antoch G; Heusner TA
Acta Radiol; 2012 Jul; 53(6):628-36. PubMed ID: 22761341
[TBL] [Abstract][Full Text] [Related]
15. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of
Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
[TBL] [Abstract][Full Text] [Related]
17. The Role of
Fukumoto K; Fukui T; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Sugiyama T; Kato K; Yokoi K
World J Surg; 2017 Jul; 41(7):1828-1833. PubMed ID: 28265732
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors.
Kaira K; Murakami H; Miura S; Kaira R; Akamatsu H; Kimura M; Ono A; Tsuya A; Nakamura Y; Naito T; Takahashi T; Endo M; Yamamoto N
Ann Nucl Med; 2011 May; 25(4):247-53. PubMed ID: 21174178
[TBL] [Abstract][Full Text] [Related]
19. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
[TBL] [Abstract][Full Text] [Related]
20. Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT - RECIST 1.1 vs. PERCIST 1.0.
Odawara S; Kitajima K; Katsuura T; Kurahashi Y; Shinohara H; Yamakado K
Eur J Radiol; 2018 Apr; 101():65-71. PubMed ID: 29571803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
